FDA Reviewers Flag Inconsistent Data for Rexulti in PTSD

(Medage today) – The question of whether Brexpiprazole (Rexulti) is effective because the extra treatment for post -traumatic stress disorder (SSPT) will be debated by the FDA Consultative Committee of the FDA on Friday. The atypical antipsychotic is being examined as …